Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
99.86% 0.13%
General Information
Revision date
2016-02-29
Product name
CEDIA Multi-Drug Calibrators, CEDIA Opiate 2K Control, CEDIA Negative
Product Synonyms
1815326 CEDIA® Multi-Drug Calibrator, Primary Cutoffs
CAS No.
26628-22-8
1.2.1 Relevant identified uses
In vitro diagnostic kit
Emergency telephone
1-(800) 424-9300, 1-(703) 527-3887
Icons in SDS
Company Information
company name
Microgenics Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
techservice.mgc@thermofisher.com
GHS Information
Signal word
Warning
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) Mixture not yet fully tested. 1272/2008 [GHS] Directive 67/548/EEC or Mixture not yet fully tested. 1999/45/EC
CLP CLASSIFICATION
None required EUH032 - Contact with acids liberates very toxic gas.
Signal word
Warning Caution US Hazard overview Mixture not yet fully tested. This product contains human urine and should be treated/handled as a potential biohazard. Note This mixture is classified as hazardous according to Directive 1999/45/EC, Regulation EC No 1272/2008 (EU-CLP), and applicable US regulations. The pharmacological, toxicological, and ecological properties of this mixture have not been fully characterized. The CLP/GHS classifications are based on Regulation (EC) 1272/2008. The EU symbol/indicator of danger, R Phrases and Safety Advice are based on Directive 1999/45/EC. 10005161SDS CEDIA® Drugs of Abuse Urine Calibrators and Controls SDS Revision Date: 29 February 2016, Version 3 Page 2 of 13
Hazard statements
CLP/GHS precautionary None required EU symbol/indication of danger Xn - Harmful Risk (R) Phrase(s) R32 - Contact with acids liberates very toxic gas.
Precautionary statements
S2 - Keep out of reach of children. S23 - Do not breathe vapor/spray. S24 - Avoid contact with skin. S37 - Wear suitable protective gloves. S50 - Do not mix with acids.
2.3 Other hazards
No data specific for the mixture were identified. This product contains human urine and should be treated/handled as a potential biohazard. All such human urine has been derived from donors tested individually and shown by FDA approved methods to be free from antibodies to Human Immune Deficiency Virus and Hepatitis B and C. As no test method can offer complete assurance that these or other infectious agents are not present, this product should be handled using standard biosafety precautions.
